Ailing UK life sciences sector will need further treatment
The life sciences sector is that rarest of things: an area where the UK government has generally agreed with itself.
Reports have consistently espoused the importance of the sector and the UK’s strengths in terms of its leading universities, a strong research base, good skills and a centralised system in the NHS. The life sciences industrial strategy in 2017 laid out a “vision” to be a “global hub . . . for clinical research and medical innovation”.
This story originally appeared on: Financial Times - Author:Helen Thomas
